See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2017_Viracta_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,231,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 10,939,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,255,496 |
| 9 | ResearchAndDevelopmentExpense | 22,572,834 |
| 10 | remainder_Expenses | 1,863,980 |
| 11 | remainder_Revenues | 2,637,386 |
| 12 | remainder_NetIncome | 1,391,437 |
| 13 | remainder_ComprehensiveNetIncome | -9,431 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,234,000 |
| 1 | Liabilities | 10,939,000 |
| 2 | Expenses | 40,692,310 |
| 3 | Revenues | 2,637,386 |
| 4 | StockholdersEquity | 32,295,000 |
| 5 | NetIncome | -36,663,487 |
| 6 | ComprehensiveNetIncome | -36,668,202 |
| 7 | BaseVar | 49,451,782 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.25 |
| 9 | EconomicCapitalRatio | 2.49 |